ATS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
John A. Meyer
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Meyer, J. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Meyer, J. A.

Ann Thorac Surg 1986;42:668-669
© 1986 The Society of Thoracic Surgeons


Articles

Five-Year Survival in Treated Stage I and II Small Cell Carcinoma of the Lung

John A. Meyer, M.D.*

From the Department of Surgery, State University of New York College of Medicine, Syracuse, NY

Accepted for publication February 5, 1986.

* Address reprint requests to Dr. Meyer, 750 E Adams St, Syracuse, NY 13210

Ten consecutive patients were treated more than five years ago, for small cell carcinoma of the lung in clinical and surgical stages I or II. Patients underwent initial surgical resection, followed by intensive combination chemotherapy for at least a year, or to limit of tolerance. Four patients were classified as stage II, T2 N1; 4 had T2 N0; and 2 had T1 N0. One patient (T2 N1) died of tumor recurrence in the central nervous system 14 months after resection. Two died of other causes before five years, one (T2 N0) of a pulmonary embolus on the seventh postoperative day, and the other (T2 N1) of carcinoma of the prostate at 50 months.

Seven patients (70%) remained well and disease-free at five years postoperation. Two of the 7 died of unrelated causes, one (T2 N0) at 72 months and one (T2 N1) at 108 months. Five remain well at 61 to 112 months after resection. Although this series is small, no reports have shown comparable survival in a defined group of small cell carcinoma patients treated nonoperatively or by surgical resection alone.




This article has been cited by other articles:


Home page
Ann. Thorac. Surg.Home page
M. Inoue, S. Miyoshi, T. Yasumitsu, T. Mori, K. Iuchi, H. Maeda, and H. Matsuda
Surgical results for small cell lung cancer based on the new TNM staging system
Ann. Thorac. Surg., November 1, 2000; 70(5): 1615 - 1619.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
D. B. Skinner
Technical and scientific advances in general thoracic surgery
Ann. Thorac. Surg., January 1, 1990; 49(1): 14 - 25.
[PDF]


Home page
Ann. Thorac. Surg.Home page
B. L. Graham Jr., L. Balducci, T. Khansur, M. L. Dalton, and B. Lambuth
Surgery in Small Cell Lung Cancer
Ann. Thorac. Surg., June 1, 1988; 45(6): 687 - 692.
[Abstract] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 1986 by The Society of Thoracic Surgeons.